Anti-cancer Effect of Nimesulide and Its COX-2-independent Mechanisms

ZHANG Li,FENG Kun,LIU Wen-zhong,LU Hong,PENG Yan-shen

DOI: https://doi.org/10.3969/j.issn.1672-2353.2011.13.017

2011-01-01

Abstract:Objective To elucidate the effect of a selective COX-2 inhibitor,Nimesulide,on the MKN28 cancer xenografts and its COX-2-independent mechanisms.Methods The western-blotting method was used to select the lowest COX-2 expression cell line from human gastric cancer cell lines of-MKN45,AGS,MKN28,SGC-7901 and BGC-823.Then the cell line was injected subcutaneously into the right forelimb of BALB/C athymic mice.Twenty-four athymic mice were divided into the model and treatment groups.300 mg/L nimesulide was orally administered to the mice of treatment group.The tumor volumes were measured every ten days and the mice were sacrificed after forty days.All tumors were dissected.The expressions of NF-κB and p21WAF1 were detected by immunohistochemical assays,and the expression of PPAR-γmRNA was detected by RT-PCR.Results The lowest expression of COX-2 of gastric cell lines was MKN28.Tumor volume of treatment group was significantly smaller than that of model group(P0.05).Nimesulide can inhibit the growth of lowest-COX-2 expression MKN28 cancer xenografts.The expression of NF-κB in treatment group was significantly lower than that of model group(P0.05),while the expression of p21WAF1 was significantly higher than that of model group(P0.05),And the expression of PPAR-γmRNA was enhanced in treatment group.Conclusion Selective COX-2 inhibitor,Nimesulide,has anticancer effects on lowest-COX-2 expression MKN28 cancer xenografts.Nimesulide could induce enhancement of PPAR-γmRNA and p21WAF1 expression,and reduce the expression of NF-κB,that may contribute to its anti-tumor effect in a COX-2 independent pathway.